by Peter Ciszewski | Apr 8, 2021
Dawn Laney, MS, CGC, CCRC, Genetic Counselor and Director of Emory Genetic Clinical Trials Center, discusses the importance of knowing how to talk to parents about a newborn screening result. As Ms. Laney notes, when providing results of a newborn screening...
by Peter Ciszewski | Apr 8, 2021
Miganush Stepanians, PhD, President and CEO of PROMETRIKA, a clinical research organization (CRO), discusses study designs used in rare disease clinical trials and the common struggles researchers face when designing and conducting these trials. Generally, the gold...
by Peter Ciszewski | Apr 7, 2021
Susan Thornton, CEO of Cutaneous Lymphoma Foundation, gives an overview of cutaneous lymphoma and its subtypes. Cutaneous lymphoma is a rare subtype of non-Hodgkin lymphoma that primarily affects the skin. Cutaneous lymphoma can originate in B-cells (i.e.,...
by Peter Ciszewski | Apr 7, 2021
Roberto Salvatori, MD, Medical Director, Johns Hopkins Pituitary Center and Professor of Medicine at Johns Hopkins discusses some of the challenges of diagnosing acromegaly, a rare disorder that occurs when your body makes too much growth hormone. Produced...
by Peter Ciszewski | Apr 6, 2021
Jennifer Ibrahim, MD, Head of North America Medical Affairs, Rare Disease at Sanofi Genzyme, discusses the geneticist’s role in diagnosing and treating rare genetic diseases. As Dr. Ibrahim explains, often rare diseases present with a number of symptoms, many...
